It is proposed that this article be deleted because of the following concern:
If you can address this concern by improving, copyediting, sourcing, renaming, or merging the page, please edit this page and do so. You may remove this message if you improve the article or otherwise object to deletion for any reason. Although not required, you are encouraged to explain why you object to the deletion, either in your edit summary or on the talk page. If this template is removed, do not replace it . The article may be deleted if this message remains in place for seven days, i.e., after 00:00, 4 July 2025 (UTC). Find sources: "Virginia Biotechnology Association" – news · newspapers · books · scholar · JSTOR Nominator: Please consider notifying the author/project: {{ subst:proposed deletion notify |Virginia Biotechnology Association|concern=Created by a single purpose editor. Fails [[WP:ORG]].}} ~~~~ |
Another editor has reviewed this page's proposed deletion and endorses both the proposal and the reason given above. If you remove the {{proposed deletion/dated}} tag above, please also remove this {{Proposed deletion endorsed}} tag. |
 | This article needs additional citations for verification .(May 2015) |
The Virginia Biotechnology Association (VABIO) is the statewide trade group that promotes the scientific and economic impact of the biotechnology industry in the Commonwealth of Virginia.
Headquartered at the Virginia BioTechnology Research Park in Richmond, Virginia, VABIO was founded in 1992, and incorporated in the Commonwealth of Virginia as a non-profit 501(c)(6) trade association. It is the official state affiliate of the Biotechnology Industry Organization (BIO).
VABIO sponsors student internships, workforce development initiatives and serves as the primary contact point for the media, government officials, researchers and students regarding the bioscience industry in Virginia. Its activities are governed by a board of directors composed of twenty-four leaders representing all segments of the bioscience community. The first full-time executive director for VABIO, Mark A. Herzog, was hired in August 2000. The current CEO is John L. Newby II. [1]
The Virginia Biotechnology Association is one of the three founding partners of Mid-Atlantic Bio, the first regional bioscience convention that combines academia, the commercial bioscience industry, and the venture capital community in one major event.
VABIO also produces the Virginia Bioscience Blog and the Virginia Bioscience Podcast.
